Skip to main content
. 2022 Jul 13;11(3):1375–1390. doi: 10.1007/s40120-022-00384-2

Table 2.

Adverse events occurring in more than 1% of patients and classified by investigators as related to teriflunomide

Adverse event Frequency, n (%)
Alopecia 24 (8.5)
Diarrhea 16 (5.7)
Elevated alanine aminotransferase 14 (5)
Nausea 4 (1.4)
Dizziness 4 (1.4)
Elevated gamma-glutamyltransferase 3 (1.1)
MS relapse (reported as an adverse event) 3 (1.1)